Genocea announces new data that supports novel approach for development of HSV-2 vaccine
22:57 EDT 5 Aug 2012 | The Medical News
Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).
Original Article: Genocea announces new data that supports novel approach for development of HSV-2 vaccine
More From BioPortfolio on "Genocea announces new data that supports novel approach for development of HSV-2 vaccine"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
